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As part of its ongoing investigation of the multistate outbreak of fungal infections, the Centers for Disease 
Control and Prevention (CDC) continues to assess and revise interim guidance to clinicians involved in 
the management of patients who received injections with contaminated steroid products distributed by the 
New England Compounding Center (NECC).1 Since early in the outbreak, CDC has recommended 
against antifungal prophylactic or presumptive treatment of exposed asymptomatic patients in the 
absence of diagnostic testing with results indicating meningitis. This recommendation remains 
unchanged.
Nevertheless, CDC recognizes the need to assist clinicians in managing asymptomatic patients who 
received epidural or paraspinal injections with contaminated steroid products.1 CDC is releasing updated 
interim guidance to clinicians based on new data that has become available during this investigation.
CDC analysis suggests that the period of greatest risk for development of fungal meningitis among 
patients who received epidural or paraspinal injections with contaminated products1 is during the first 6 
weeks (42 days) after injection; therefore, additional monitoring of these patients should be considered. 
Accordingly, CDC provides guidance for asymptomatic patients who received epidural or paraspinal 
injections with contaminated steroid product1 within the last 6 weeks (42 days), and those who received 
such products longer than 6 weeks (42 days) ago. For specific details about the updated guidance, see 
Guidance on Management of Asymptomatic Patients Who Received Epidural or Paraspinal Injections 
with Contaminated Steroid Products
(http://www.cdc.gov/hai/outbreaks/clinicians/interim guidance asymptomatic persons.html).
As stated above, CDC does not recommend initiation of antifungal treatment in the absence of diagnostic 
test results indicating fungal meningitis in exposed patients who are asymptomatic. Currently available 
data do not suggest an added benefit to this approach in comparison to the strategies outlined in the 
updated guidance, and patients may experience serious adverse drug events associated with treatment.
The guidance and estimates are based on data currently available to CDC. Additional data that are 
gathered from existing and newly reported cases of infection, when combined with previous data, may 
alter the guidance and estimates. Clinicians and others with patients under their care who use the 
guidance and estimates should check CDC’s website for the most up-to-date information, since it is 
subject to change periodically.
For the most recent information about this and other clinical guidance as well as case definitions being 
used in the current investigation, visit CDC’s Clinician Guidance web page 
(http://www.cdc.gov/hai/outbreaks/clinicians/index.html).
1 NECC lots of methylprednisolone acetate (PF) 80mg/ml:
Methylprednisolone Acetate (PF) 80 mg/ml Injection, Lot #05212012@Q8, BUD 11/17/2012 
Methylprednisolone Acetate (p f ) 80 mg/ml Injection, Lot #0Q292012@2Q, BUD 12/2Q/2012 
Methylprednisolone Acetate (p f ) 80 mg/ml Injection, Lot #08102012@51, BUD 2/Q/2013
The Centers for Disease Control and Prevention (CDC) protects people's health and safety by preventing 
and controlling diseases and injuries; enhances health decisions by providing credible information on 
critical health issues; and promotes healthy living through strong partnerships with local, national, and 
international organizations.
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